麻豆传媒

Dr. Pavia is a pediatric infectious disease expert who can provide expert commentary on vaccines, infectious disease and related trending topics. He has become a trusted source for top national media.

He received his bachelor's degree and medical degree at Brown University. He trained in internal medicine and pediatrics at Dartmouth and the University of Utah. At the Centers for Disease Control and Prevention, Dr. Pavia trained in Public Health Epidemiology as an Epidemic Intelligence Service (EIS) officer and a Preventive Medicine Resident. Additionally, Dr. Pavia completed a fellowship in pediatric and adult infectious diseases at the University of Utah. He joined the faculty at the University of Utah in 1991. In 2003 Dr. Pavia became the George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases, where he mentors a dynamic and productive team of faculty and fellows. He also serves as Director of Hospital Epidemiology at Primary Children's Hospital and Associate Director of Antimicrobial Stewardship. Dr. Pavia is a member of the Society for Pediatric Research. He is a Fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Dr. Pavia is a member of the National Academy of Science Engineering and Medicine Forum on Preparedness. He was recently Vice Chair and Chair of the Program Committee for IDWeek and served two terms on the CDC Board of Scientific Counselors. He has served as a member of the Board of Directors the Infectious Disease Society of America (IDSA) and past chair of the Pandemic Influenza Task Force and past Chair of the National and Global Public Policy Committee. Dr. Pavia served as a member of the National Vaccine Advisory Committee and chaired the Vaccine Safety Working Group, was an inaugural member of the National Biodefense Science Board (NBSB) and chaired the Influenza Working Group, and co-chaired the Personal Preparedness Working Group of the NBSB from 2008-2010. Dr. Pavia has served on several Institute of Medicine Committees including 鈥淎ntivirals for Pandemic Influenza: Guidance on Developing and Distribution and Dispensing System,鈥� and 鈥淧repositioned Medical Countermeasure for the Public,鈥� and is a frequent consultant for CDC. He is an associate Editor of the Sanford Guide to Antimicrobial Therapy and is on the editorial board the Journal of the Pediatric Infectious Disease Society and a reviewer for numerous journals. He has published more than 250 peer-reviewed scientific articles, textbook chapters, reviews and scientific abstracts. His research interests include the epidemiology of influenza and other emerging respiratory infections, pneumonia, vaccine preventable diseases, emerging infections, and HIV/ AIDS, with a particular interest in infections of pregnant women and their children. He has been the principal investigator or co-investigator on grants from the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Centers for Disease Control and Prevention.

Dr. Pavia received his undergraduate and medical degrees from Brown University. He completed his residency at Dartmouth Hitchcock Medical Center and served as Chief Resident. He then served as an officer in the Epidemic Intelligence Service at the Centers for Disease Control and Prevention and completed a residency in Preventive Medicine. He completed fellowship training in pediatric and adult infectious diseases at the University of Utah. Dr. Pavia is currently the George and Esther Gross Presidential Professor at the University of Utah and is Chief of the Division of Pediatric Infectious Diseases. His academic interests include the epidemiology, diagnosis and management of emerging infectious diseases including influenza, respiratory infections and diarrheal diseases. He is also keenly interested in HIV/AIDS and has been involved in HIV clinical care and research since the 1980s.

Dr. Licciardone鈥檚 research focuses on the prevention and treatment of chronic pain. He is the first recipient of a Regents Professorship awarded by the Texas College of Osteopathic Medicine since it was established 50 years ago. He also holds the Osteopathic Heritage Foundation Distinguished Chair in Clinical Research in honor of Drs. David Richards and Benjamin Cohen, former President and Provost of the University of North Texas Health Science Center. He presently directs the Osteopathic Research Center, including its PRECISION Pain Research Registry. The latter is the 鈥渇irst-in-the-nation鈥� pain research registry, which studies precision medicine and biopsychosocial approaches to pain management. He received a Midcareer Investigator Award from the National Institutes of Health (NIH), served as an expert panelist for NIH in the area of chronic pain, and completed a four-year term on its National Advisory Council for Complementary and Integrative Health. He directed the OSTEOPATHIC Trial, a five-year study funded by NIH that demonstrated substantial improvements in and recovery from chronic low back pain with osteopathic manipulation. He is presently a Co-Investigator in the $14 million Prevention of Acute to Chronic Back Pain Trial (PACBACK Trial) sponsored by NIH, and recently served on the Work Group that developed NIH鈥檚 Federal Pain Research Strategy. Internationally, Dr. Licciardone has served as a consultant to the World Health Organization on regulatory and safety issues relating to osteopathy in Europe and other nations. He gave the keynote address at Advancing Osteopathy 2008, a conference celebrating the 10th anniversary of recognition of osteopaths in the United Kingdom鈥檚 National Health Service, including a preconference reception with His Royal Highness, The Prince of Wales. He has also met and advised two former United States Surgeons General on the role of osteopathic physicians within the American health care system. The American Osteopathic Foundation has honored Dr. Licciardone with its Gutensohn-Denslow Award for devoted lifetime service and contributions to research and education within the osteopathic profession. 

Dr. Peter Bidey has served on the faculty of PCOM since 2012. Since 2018, he has acted as vice chair (and previously, medical director) of the Department of Family Medicine, and most recently, as assistant dean of clinical curricular integration. He is a clerkship director and co-course director for myriad ambulatory, family medicine, and primary care skills courses. In 2023, he was named dean of the osteopathic medicine program. 

He is on staff at Main Line Health 鈥� Lankenau Medical Center. He previously served as an attending physician, as director of medical education and as program director of the PCOM/Suburban Community Hospital Family Medicine Residency at Suburban Community Hospital in Norristown.

Dr. Bidey serves as president of the Pennsylvania Osteopathic Family Physicians Society (POFPS). He sits on the Board of Governors of the American College of Osteopathic Family Physicians (ACOFP) and acts as department chair of various ACOFP committees. He also chairs the NBOME Clinical Decision-Making and Key Features Content Committee. He is a member of ACOFP, POFPS, the American Osteopathic Association, and the Pennsylvania Osteopathic Medical Association. At PCOM, he is a member of the Student Professional Conduct Committee and faculty advisor to the PCOM Student Chapter of ACOFP and the PCOM Student Chapter of Primary Care Progress.

Dr. Bidey has been recognized for his dedicated work both as a teacher and clinician. His honors include Outstanding Advisor of the Year (PCOM; received three times), Osteopathic Family Medicine Educator of the Year (ACOFP), the Frederick J. Solomon, DO FACGP Award for Merit (POFPS), and Case Writer of the Year (NBOME), among others.  

Dr. Bidey holds a bachelor's degree from Duquesne University, a doctor of osteopathic medicine degree from PCOM, and a master of science in education degree from the University of Pennsylvania. Board-certified by the AOBFP in family medicine and OMT, he is a fellow of the American College of Osteopathic Family Physicians.

 


Dr. William Schaffner is Professor of Preventive Medicine with a primary appointment in the Department of Health Policy as well as Professor of Medicine in the Division of Infectious Diseases at the Vanderbilt University School of Medicine, Nashville, Tennessee.
After graduating from Yale in 1957, Schaffner attended the University of Freiburg, Germany as a Fulbright Scholar. He graduated from Cornell University Medical College in 1962 and completed residency training and a Fellowship in Infectious Diseases at Vanderbilt. He then was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention in Atlanta for two years. While with the CDC, Dr. Schaffner became intimately familiar with public health and investigated outbreaks of communicable diseases both in the United States and abroad. These experiences were a formative stimulus for his subsequent career. He returned to Vanderbilt after that tour of duty, joining the faculty and establishing a long collaboration with the Tennessee Department of Health.
Dr. Schaffner's primary interest has been the prevention of infectious diseases. He is a strong proponent of collaboration between academic medical centers and public health institutions. He has worked extensively on the effective use of vaccines in both pediatric and adult populations and has been a member of numerous expert advisory committees that establish national vaccine policy.
Dr. Schaffner is the current Medical Director and past president of the National Foundation for Infectious Diseases and has served on the Executive Board for the Infectious Diseases Society of America. 
Dr. Schaffner is committed to communicating about medicine to the general public. He regards this as a teaching opportunity. As such, he is often invited to comment in local and national media on communicable disease issues, translating research advances and public health events into language that the public can understand.